NCI | Technology Transfer

TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Read more about TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Monaco
93922310.3
Filed on 1993-09-22

TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Read more about TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Luxembourg
93922310.3
Filed on 1993-09-22

TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Read more about TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Italy
93922310.3
Filed on 1993-09-22

TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Read more about TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Ireland
93922310.3
Filed on 1993-09-22

TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Read more about TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

United Kingdom
93922310.3
Filed on 1993-09-22

TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

Read more about TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER

France
93922310.3
Filed on 1993-09-22

Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection

Read more about Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection

Singapore
200600656-3
Filed on 2004-07-30

Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection

Read more about Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection

Mexico
PA/a/2006/001170
Filed on 2004-07-30

Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection2006543958

Read more about Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection2006543958

Japan
2006-522041
Filed on 2004-07-30

Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection

Read more about Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detection

Israel
173471
Filed on 2004-07-30

Subscribe to NCI